photo of

Details

Role Team Leader / Senior Research Fellow
Dr Claire von Mollendorf is a medical epidemiologist currently working as a senior research fellow in the New Vaccines and Asia-Pacific Research Groups at the Murdoch Children’s Research Unit (MCRI). She has been with MCRI since 2017 and is an investigator on a number of projects in Mongolia. She is also the co-principal investigator on a Coalition for Epidemic Preparedness Innovations (CEPI) funded COVID-19 vaccine booster study. Dr von Mollendorf has an honorary appointment as a Senior Fellow within the University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics.

Dr von Mollendorf is the project manager for a National Health & Medical Research Council Centre of Research Excellence for Pneumococcal Disease Control in the Asia-Pacific (CRE-PDC) which aims to address research gaps related to pneumococcal conjugate vaccine use in the Asia-Pacific region. It also focuses on building research and leadership capacity for early career researchers in the region.

Prior to 2017 she worked in different research areas, including women's health, HIV and pneumococcal research, in South Africa. Her passion and involvement in research has spanned over an 20 year period and has included adults and children, some vulnerable groups and ranged from clinical trials to observational studies. She also has an interest in the impact of environmental pollution on health.
Dr Claire von Mollendorf is a medical epidemiologist currently working as a senior research fellow in the New Vaccines and Asia-Pacific Research Groups at the Murdoch Children’s Research Unit (MCRI). She has been with MCRI since 2017 and is an...
Dr Claire von Mollendorf is a medical epidemiologist currently working as a senior research fellow in the New Vaccines and Asia-Pacific Research Groups at the Murdoch Children’s Research Unit (MCRI). She has been with MCRI since 2017 and is an investigator on a number of projects in Mongolia. She is also the co-principal investigator on a Coalition for Epidemic Preparedness Innovations (CEPI) funded COVID-19 vaccine booster study. Dr von Mollendorf has an honorary appointment as a Senior Fellow within the University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics.

Dr von Mollendorf is the project manager for a National Health & Medical Research Council Centre of Research Excellence for Pneumococcal Disease Control in the Asia-Pacific (CRE-PDC) which aims to address research gaps related to pneumococcal conjugate vaccine use in the Asia-Pacific region. It also focuses on building research and leadership capacity for early career researchers in the region.

Prior to 2017 she worked in different research areas, including women's health, HIV and pneumococcal research, in South Africa. Her passion and involvement in research has spanned over an 20 year period and has included adults and children, some vulnerable groups and ranged from clinical trials to observational studies. She also has an interest in the impact of environmental pollution on health.

Top Publications

  • Valley-Omar, Z, Iyengar, P, von Mollendorf, C, Tempia, S, Moerdyk, A, Hellferscee, O, Martinson, N, McMorrow, M, Variava, E, Masonoke, K, et al. Intra-host and intra-household diversity of influenza A viruses during household transmissions in the 2013 season in 2 peri-urban communities of South Africa.. PLoS One 13(5) : e0198101 2018
    view publication
  • Wong, KK-L, von Mollendorf, C, Martinson, N, Norris, S, Tempia, S, Walaza, S, Variava, E, McMorrow, ML, Madhi, S, Cohen, C, et al. Healthcare utilization for common infectious disease syndromes in Soweto and Klerksdorp, South Africa.. Pan Afr Med J 30: 271 2018
    view publication
  • Tempia, S, Walaza, S, Moyes, J, Cohen, AL, von Mollendorf, C, McMorrow, ML, Treurnicht, FK, Venter, M, Pretorius, M, Hellferscee, O, et al. Attributable Fraction of Influenza Virus Detection to Mild and Severe Respiratory Illnesses in HIV-Infected and HIV-Uninfected Patients, South Africa, 2012-2016.. Emerg Infect Dis 23(7) : 1124 -1132 2017
    view publication
  • Cohen, C, von Mollendorf, C, de Gouveia, L, Lengana, S, Meiring, S, Quan, V, Nguweneza, A, Moore, DP, Reubenson, G, Moshe, M, et al. Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study.. Lancet Glob Health 5(3) : e359 -e369 2017
    view publication
  • Tempia, S, Walaza, S, Moyes, J, Cohen, AL, von Mollendorf, C, Treurnicht, FK, Venter, M, Pretorius, M, Hellferscee, O, Mtshali, S, et al. Risk Factors for Influenza-Associated Severe Acute Respiratory Illness Hospitalization in South Africa, 2012-2015.. Open Forum Infect Dis 4(1) : ofw262 2017
    view publication

Page 11 of 18